Powder: -20°C for 3 years | In solvent: -80°C for 1 year
YH-53 是一种有效的3CLpro 抑制剂,对 SARS-CoV-1 3CLpro 和 SARS-CoV-2 3CLpro 的Ki 值分别为 6.3 nM、34.7 nM。YH-53 能够有效阻断 SARS-CoV-2 复制。YH-53 是一种具有独特苯并噻唑基酮的拟肽化合物。YH-53 具有用于研究新冠病毒的潜力。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
5 mg | ¥ 4,780 | 8-10周 | ||
25 mg | ¥ 16,600 | 8-10周 | ||
50 mg | ¥ 21,600 | 8-10周 |
产品描述 | YH-53 is a potent 3CLpro inhibitor, exhibiting K i values of 6.3 nM and 34.7 nM against SARS-CoV-1 3CLpro and SARS-CoV-2 3CLpro, respectively. This peptidomimetic compound, characterized by its unique benzothiazolyl ketone structure, significantly inhibits SARS-CoV-2 replication, highlighting its potential in COVID-19 research [1] [2]. |
体外活性 | YH-53 (1-25 μM; for 24 h) potently reduces copies of total RNA with increased concentrations in VeroE6/TMPRSS2 cells [1]. YH-53 (1, 5, 10, 15, 20, 25 μM; for 48 h) with 10 μM completely blocks the viral proliferation against SARS-CoV-2 were examined by a cytopathic effect (CPE) assay in Vero cells [1]. YH-53 (10, 100 μM; for 24 h) has no cytotoxicity with a CC 50 value of >100 μM in vero cells [1]. YH-53 (10 μM) moderately inhibits CYP1A2, CYP2D6, and CYP2C8 (26.6%, 38.0%, 66.4%, respectively). YH-53 has no inhibition on CYP2C9 and CYP3A4 [1]. YH-53 inhibits SARS-CoV 3CL pro with an IC 50 of 0.74 μM. RT-PCR [1] Cell Line: VeroE6/TMPRSS2 cells Concentration: 1, 5, 10, 15, 20, 25 μM Incubation Time: 24 hours Result: Efficiently reduced copies of total RNA. |
体内活性 | YH-53 (0.1 mg/kg; iv) exhibits a T 1/2 of 2.97 hours, an AUC 0–∞ of 19.7 ng h/mL, a V d of 3.51 L/kg in rats [1]. YH-53 (0.5 mg/kg; oral) exhibits a T 1/2 of 9.64 hours, an AUC 0–∞ of 3.49 ng h/mL, a C max of 1.08 ng/mL in rats [1]. Animal Model: Rats [1] Dosage: 0.1 mg/kg (Pharmacokinetic Analysis) Administration: IV Result: Had a T 1/2 of 2.97 hours, an AUC 0–∞ of 19.7 ng h/mL, a V d of 3.51 L/kg. |
分子量 | 575.68 |
分子式 | C30H33N5O5S |
CAS No. | 1471484-62-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
YH-53 1471484-62-4 YH53 YH 53 Inhibitor inhibitor inhibit